CTKBCytek Biosciences, Inc.同业对比
Cytek Biosciences, Inc. 与SIC 3826 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTKB本股 | $576M#8 | — | 1.8x#5 | 2.9x#5 | 0.5%#8 | -1005.3%#15 | -20.0%#9 | -20.3%#9 | — | — | 23.5%#4 | — |
| A | $39.7B#2 | 28.2x#4 | 5.6x#9 | 5.7x#7 | 6.7%#2 | 1.1%#6 | 21.3%#1 | 18.3%#2 | 16.1%#2 | — | 18.1%#5 | 0.7%#1 |
| ALMR | $1.7B#6 | — | — | — | — | — | — | — | — | — | — | — |
| ASTC | $12M#12 | 27.3x#3 | 1.0x#3 | 12.0x#9 | -41.2%#15 | -18.7%#7 | -1473.4%#15 | -113.9%#13 | -71.6%#9 | 2#7 | — | — |
| AVTR | $8.5B#5 | — | 1.5x#4 | 1.3x#3 | -3.4%#10 | -174.5%#13 | -3.8%#7 | -9.5%#7 | -2.7%#7 | 4#3 | — | — |
| BFNH | — | — | — | — | 9.0%#1 | -163.4%#12 | -261.8%#13 | — | — | — | — | — |
| BIO | — | 55.1x#7 | — | — | 0.7%#6 | 141.2%#2 | 1.8%#5 | 11.1%#3 | 0.5%#3 | — | 31.1%#3 | — |
| BIO.B | — | 49.7x#6 | — | — | 0.7%#6 | 141.2%#2 | 1.8%#5 | 11.1%#3 | 0.5%#3 | — | -34.6%#6 | — |
| BNGO | $13M#11 | — | 0.3x#1 | 0.4x#2 | -7.4%#12 | 76.4%#4 | -116.9%#11 | -70.5%#11 | — | — | -64.8%#7 | — |
| BRKR | $9.5B#4 | — | 3.9x#7 | 2.8x#4 | 2.1%#4 | -107.3%#9 | 2.0%#3 | -0.3%#5 | 0.0%#5 | 3#4 | 50.0%#2 | 0.2%#2 |
| BRKRP | $68.2B#1 | — | 27.8x#11 | 19.9x#10 | 2.1%#4 | -107.3%#9 | 2.0%#3 | -0.3%#5 | 0.0%#5 | 3#4 | — | 0.0%#3 |
| EYPT | $1.0B#7 | — | 4.3x#8 | 31.9x#11 | -27.5%#14 | -77.2%#8 | -776.0%#14 | -100.6%#12 | — | — | — | — |
| HBIO | $27M#10 | 0.7x#1 | 2.7x#6 | 0.3x#1 | -8.1%#13 | -357.1%#14 | -56.1%#10 | -564.4%#14 | -124.1%#10 | — | — | — |
| ILMN | $29.2B#3 | 35.1x#5 | 10.9x#10 | 6.7x#8 | -0.7%#9 | 169.5%#1 | 18.6%#2 | 31.8%#1 | 23.4%#1 | 7#1 | 77.5%#1 | — |
| LAB | $310M#9 | 4.0x#2 | 0.6x#2 | 3.6x#6 | -6.2%#11 | 46.1%#5 | -129.2%#12 | -13.3%#8 | — | 5#2 | — | — |
| LCTC | — | — | — | — | 5.7%#3 | -134.6%#11 | -13.6%#8 | -62.5%#10 | -44.0%#8 | 3#4 | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-07-30。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议